These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24046748)

  • 1. Pathophysiological roles of FGF signaling in the heart.
    Itoh N; Ohta H
    Front Physiol; 2013 Sep; 4():247. PubMed ID: 24046748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II-induced cardiac hypertrophy and fibrosis are promoted in mice lacking Fgf16.
    Matsumoto E; Sasaki S; Kinoshita H; Kito T; Ohta H; Konishi M; Kuwahara K; Nakao K; Itoh N
    Genes Cells; 2013 Jul; 18(7):544-53. PubMed ID: 23600527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of FGF Signals in Heart Development, Health, and Disease.
    Itoh N; Ohta H; Nakayama Y; Konishi M
    Front Cell Dev Biol; 2016; 4():110. PubMed ID: 27803896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine FGFs: Evolution, Physiology, Pathophysiology, and Pharmacotherapy.
    Itoh N; Ohta H; Konishi M
    Front Endocrinol (Lausanne); 2015; 6():154. PubMed ID: 26483756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease.
    Itoh N
    Cell Tissue Res; 2010 Oct; 342(1):1-11. PubMed ID: 20730630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Altered Mineral Metabolism on Pathological Cardiac Remodeling in Elevated Fibroblast Growth Factor 23.
    Leifheit-Nestler M; Richter B; Basaran M; Nespor J; Vogt I; Alesutan I; Voelkl J; Lang F; Heineke J; Krick S; Haffner D
    Front Endocrinol (Lausanne); 2018; 9():333. PubMed ID: 29977226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac actions of fibroblast growth factor 23.
    Faul C
    Bone; 2017 Jul; 100():69-79. PubMed ID: 27725315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracrine Effects of FGF23 on the Heart.
    Leifheit-Nestler M; Haffner D
    Front Endocrinol (Lausanne); 2018; 9():278. PubMed ID: 29892269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structural biology of the FGF19 subfamily.
    Beenken A; Mohammadi M
    Adv Exp Med Biol; 2012; 728():1-24. PubMed ID: 22396159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of FGFs as Adipokines in Adipose Tissue Development, Remodeling, and Metabolism.
    Ohta H; Itoh N
    Front Endocrinol (Lausanne); 2014; 5():18. PubMed ID: 24605108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structures of ligand-occupied β-Klotho complexes reveal a molecular mechanism underlying endocrine FGF specificity and activity.
    Kuzina ES; Ung PM; Mohanty J; Tome F; Choi J; Pardon E; Steyaert J; Lax I; Schlessinger A; Schlessinger J; Lee S
    Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7819-7824. PubMed ID: 30944224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique FGF23 with the ability to activate FGFR signaling through both αKlotho and βKlotho.
    Wu X; Weiszmann J; Ge H; Baribault H; Stevens J; Hawkins N; Vonderfecht S; Gardner J; Gupte J; Sheng J; Wang M; Li Y
    J Mol Biol; 2012 Apr; 418(1-2):82-9. PubMed ID: 22370560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.
    Leifheit-Nestler M; Große Siemer R; Flasbart K; Richter B; Kirchhoff F; Ziegler WH; Klintschar M; Becker JU; Erbersdobler A; Aufricht C; Seeman T; Fischer DC; Faul C; Haffner D
    Nephrol Dial Transplant; 2016 Jul; 31(7):1088-99. PubMed ID: 26681731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the physical interactions in the FGF21/FGFR/β-Klotho complex: structural requirements and implications in FGF21 signaling.
    Yie J; Wang W; Deng L; Tam LT; Stevens J; Chen MM; Li Y; Xu J; Lindberg R; Hecht R; Véniant M; Chen C; Wang M
    Chem Biol Drug Des; 2012 Apr; 79(4):398-410. PubMed ID: 22248288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonistic β-Klotho antibody mimics fibroblast growth factor 21 (FGF21) functions.
    Min X; Weiszmann J; Johnstone S; Wang W; Yu X; Romanow W; Thibault S; Li Y; Wang Z
    J Biol Chem; 2018 Sep; 293(38):14678-14688. PubMed ID: 30068552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer.
    Ewendt F; Feger M; Föller M
    Front Cell Dev Biol; 2020; 8():601006. PubMed ID: 33520985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation.
    Goetz R; Nakada Y; Hu MC; Kurosu H; Wang L; Nakatani T; Shi M; Eliseenkova AV; Razzaque MS; Moe OW; Kuro-o M; Mohammadi M
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):407-12. PubMed ID: 19966287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structures of β-klotho reveal a 'zip code'-like mechanism for endocrine FGF signalling.
    Lee S; Choi J; Mohanty J; Sousa LP; Tome F; Pardon E; Steyaert J; Lemmon MA; Lax I; Schlessinger J
    Nature; 2018 Jan; 553(7689):501-505. PubMed ID: 29342135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast Growth Factor (FGF) 23 and FGF Receptor 4 promote cardiac metabolic remodeling in chronic kidney disease.
    Fuchs MA; Burke EJ; Latic N; Murray S; Li H; Sparks M; Abraham D; Zhang H; Rosenberg P; Hänzelmann S; Hausmann F; Huber T; Erben R; Fisher-Wellman K; Bursac N; Wolf M; Grabner A
    Res Sq; 2023 Dec; ():. PubMed ID: 38196615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Multifunctional Contribution of FGF Signaling to Cardiac Development, Homeostasis, Disease and Repair.
    Khosravi F; Ahmadvand N; Bellusci S; Sauer H
    Front Cell Dev Biol; 2021; 9():672935. PubMed ID: 34095143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.